Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment andactivation of Ly6Clo/iNOS+ macrophages

Journal of Neuroscience

Volumn 31, Issue 27, 2011, Pages 9910-9922

  Donnelly, Dustin J ^a   Longbrake, Erin E ^a   Shawler, Todd M ^a   Kigerl, Kristina A ^a   Lai, Wenmin ^a   Amy Tovar, C ^a   Ransohoff, Richard M ^b   Popovich, Phillip G ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; LOCOMOTION; MACROPHAGE ACTIVATION; MALE; METABOLITE; MICROGLIA; MONOCYTE; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD11; ANTIGENS, LY; CELLS, CULTURED; CHEMOKINE CXCL1; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; MYELIN BASIC PROTEINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, CHEMOKINE; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES;

EID: 79960122953     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2114-11.2011     Document Type: Article

References (78)

1. Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM (2007) Local selfrenewalcan sustain CNS microglia maintenance and function throughoutadult life. Nat Neurosci 10:1538-1543.
2. Ancuta P, Wang J, Gabuzda D (2006) CD16+ monocytes produce IL-6,CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol 80:1156-1164.
3. Ancuta P, Liu KY, Misra V, Wacleche VS, Gosselin A, Zhou X, Gabuzda D(2009) Transcriptional profiling reveals developmental relationship anddistinct biological functions of CD16+ and CD16- monocyte subsets. BMC Genomics 10:403.
4. Apostolakis S, Amanatidou V, Papadakis EG, Spandidos DA (2009) Geneticdiversity of CX3CR1 gene and coronary artery disease: new insightsthrough a meta-analysis. Atherosclerosis 207:8-15.
5. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B (2007) Inflammatory monocytes recruited afterskeletal muscle injury switch into antiinflammatory macrophages tosupport myogenesis. J Exp Med 204:1057-1069.
6. Auffray C, Sieweke MH, Geissmann F (2009) Blood monocytes: development,heterogeneity, and relationship with dendritic cells. Annu Rev Immunol27:669-692.
7. Austin PJ, Moalem-Taylor G (2010) The neuro-immune balance in neuropathicpain: involvement of inflammatory immune cells, immune-likeglial cells and cytokines. J Neuroimmunol 229:26-50.
8. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG(2006) Basso Mouse Scale for locomotion detects differences in recoveryafter spinal cord injury in five common mouse strains. J Neurotrauma23:635-659.
9. Beg AA (2002) Endogenous ligands of Toll-like receptors: implications forregulating inflammatory and immune responses. Trends Immunol23:509-512.
10. Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F (1990) Immortalizationof murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol27:229-237.
11. Boddeke EW, Meigel I, Frentzel S, Biber K, Renn LQ, Gebicke-Härter P(1999) Functional expression of the fractalkine (CX3C) receptor and itsregulation by lipopolysaccharide in rat microglia. Eur J Pharmacol374:309-313.
12. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, Lee JC, Cook DN, Jung S, Lira SA, Littman DR, Ransohoff RM (2006) Control of microglial neurotoxicityby the fractalkine receptor. Nat Neurosci 9:917-924.
13. Chapman GA, Moores K, Harrison D, Campbell CA, Stewart BR, Strijbos PJ(2000) Fractalkine cleavage from neuronal membranes represents anacute event in the inflammatory response to excitotoxic brain damage. J Neurosci 20:RC87.
14. Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokinereceptors in inflammation. N Engl J Med 354:610-621.
15. Combadière C, Feumi C, Raoul W, Keller N, Rodéro M, Pézard A, Lavalette S, Houssier M, Jonet L, Picard E, Debré P, Sirinyan M, Deterre P, Ferroukhi T, Cohen SY, Chauvaud D, Jeanny JC, Chemtob S, Behar-Cohen F, Sennlaub F(2007) CX3CR1-dependent subretinal microglia cell accumulation is associatedwith cardinal features of age-related macular degeneration. J Clin Invest117:2920-2928.
16. Combadière C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, Mallat Z (2008) Combined inhibition ofCCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosisand almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117:1649-1657.
17. Davis CN, Zujovic V, Harrison JK (2004) Viral macrophage inflammatoryprotein-II and fractalkine (CX3CL1) chimeras identify molecular determinantsof affinity, efficacy, and selectivity at CX3CR1. Mol Pharmacol66:1431-1439.
18. Dénes A, Ferenczi S, Halász J, Környei Z, Kovács KJ (2008) Role of CX3CR1(fractalkine receptor) in brain damage and inflammation induced by focalcerebral ischemia in mouse. J Cereb Blood Flow Metab 28:1707-1721.
19. Donnelly DJ, Gensel JC, Ankeny DP, van Rooijen N, Popovich PG (2009)An efficient and reproducible method for quantifying macrophages indifferent experimental models of central nervous system pathology.J Neurosci Methods 181:36-44.
20. Dorgham K, Ghadiri A, Hermand P, Rodero M, Poupel L, Iga M, Hartley O, Gorochov G, Combadière C, Deterre P (2009) An engineered CX3CR1antagonist endowed with anti-inflammatory activity. J Leukoc Biol86:903-911.
21. Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, Stoppacciaro A, Chieppa M, Allavena P, Ruco L, Girolomoni G, Sinigaglia F, Vecchi A, Mantovani A (2001) Fractalkine (CX3CL1) as an amplification circuitof polarized Th1 responses. J Clin Invest 107:1173-1181.
22. Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ, Raines EW (2001) Tumor necrosis factor-alpha-converting enzyme (ADAM17)mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem276:37993-38001.
23. Gaupp S, Pitt D, Kuziel WA, Cannella B, Raine CS (2003) Experimentalautoimmune encephalomyelitis (EAE) in CCR2(-/-) mice: susceptibilityin multiple strains. Am J Pathol 162:139-150.
24. Geissmann F, Jung S, Littman DR (2003) Blood monocytes consist of twoprincipal subsets with distinct migratory properties. Immunity 19:71-82.
25. Genovese T, Mazzon E, Mariotto S, Menegazzi M, Cardali S, Conti A, Suzuki H, Bramanti P, Cuzzocrea S (2006) Modulation of nitric oxide homeostasisin a mouse model of spinal cord injury. J Neurosurg Spine4:145-153.
26. Gris D, Marsh DR, Oatway MA, Chen Y, Hamilton EF, Dekaban GA, Weaver LC (2004) Transient blockade of the CD11d/CD18 integrin reduces secondarydamage after spinal cord injury, improving sensory, autonomic,and motor function. J Neurosci 24:4043-4051.
27. Gris P, Tighe A, Thawer S, Hemphill A, Oatway M, Weaver L, Dekaban GA, Brown A (2009) Gene expression profiling in anti-CD11d mAb-treatedspinal cord-injured rats. J Neuroimmunol 209:104-113.
28. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, Botti P, Bacon KB, Feng L(1998) Role for neuronally derived fractalkine in mediating interactionsbetween neurons and CX3CR1-expressing microglia. Proc Natl Acad SciU S A 95:10896-10901.
29. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA (1999) Phylogeneticperspectives in innate immunity. Science 284:1313-1318.
30. Howard CV, Reed MG (1998) Unbiased stereology: three-dimensionalmeasurement in microscopy. New York: Springer.
31. Huang D, Shi FD, Jung S, Pien GC, Wang J, Salazar-Mather TP, He TT, Weaver JT, Ljunggren HG, Biron CA, Littman DR, Ransohoff RM (2006)The neuronal chemokine CX3CL1/fractalkine selectively recruitsNKcellsthat modify experimental autoimmune encephalomyelitis within the centralnervous system. FASEB J 20:896-905.
32. Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, Kallen KJ, Rose-John S, Ludwig A (2003) The disintegrin-like metalloproteinase ADAM10 isinvolved in constitutive cleavage of CX3CL1 (fractalkine) and regulatesCX3CL1-mediated cell-cell adhesion. Blood 102:1186-1195.
33. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ, Yoshie O (1997) Identification andmolecular characterization of fractalkine receptor CX3CR1, which mediatesboth leukocyte migration and adhesion. Cell 91:521-530.
34. Inoue A, Hasegawa H, Kohno M, Ito MR, Terada M, Imai T, Yoshie O, Nose M, Fujita S (2005) Antagonist of fractalkine (CX3CL1) delays the initiationand ameliorates the progression of lupus nephritis in MRL/lpr mice. Arthritis Rheum 52:1522-1533.
35. Isaksson J, Farooque M, Olsson Y (2005) Improved functional outcomeafter spinal cord injury in iNOS-deficient mice. Spinal Cord 43:167-170.
36. Ishida Y, Hayashi T, Goto T, Kimura A, Akimoto S, Mukaida N, Kondo T(2008) Essential involvement of CX3CR1-mediated signals in the bactericidalhost defense during septic peritonitis. J Immunol 181:4208-4218.
37. Jakeman LB, Guan Z, Wei P, Ponnappan R, Dzwonczyk R, Popovich PG, Stokes BT (2000) Traumatic spinal cord injury produced by controlledcontusion in mouse. J Neurotrauma 17:299-319.
38. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, LittmanDR (2000) Analysis of fractalkine receptor CX(3)CR1 function bytargeted deletion and green fluorescent protein reporter gene insertion.Mol Cell Biol 20:4106-4114.
39. Kigerl KA, McGaughy VM, Popovich PG (2006) Comparative analysis oflesion development and intraspinal inflammation in four strains of micefollowing spinal contusion injury. J Comp Neurol 494:578-594.
40. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG(2009) Identification of two distinct macrophage subsets with divergenteffects causing either neurotoxicity or regeneration in the injured mousespinal cord. J Neurosci 29:13435-13444.
41. King IL, Dickendesher TL, Segal BM (2009) Circulating Ly-6C+ myeloidprecursors migrate to the CNS and play a pathogenic role during autoimmunedemyelinating disease. Blood 113:3190-3197.
42. Kostadinova FI, Baba T, Ishida Y, Kondo T, Popivanova BK, Mukaida N(2010) Crucial involvement of the CX3CR1-CX3CL1 axis in dextran sulfatesodium-mediated acute colitis in mice. J Leukoc Biol 88:133-143.
43. Le W, Rowe D, Xie W, Ortiz I, He Y, Appel SH (2001) Microglial activationand dopaminergic cell injury: an in vitro model relevant to Parkinson'sdisease. J Neurosci 21:8447-8455.
44. Lee MY, Chen L, Toborek M (2009) Nicotine attenuates iNOS expressionand contributes to neuroprotection in a compressive model of spinal cordinjury. J Neurosci Res 87:937-947.
45. Lesnik P, Haskell CA, Charo IF (2003) Decreased atherosclerosis inCX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J ClinInvest 111:333-340.
46. Lin SL, Castaño AP, Nowlin BT, Lupher ML Jr, Duffield JS (2009) BonemarrowLy6Chigh monocytes are selectively recruited to injured kidney and differentiateinto functionally distinct populations. J Immunol 183:6733-6743.
47. Longbrake EE, Lai W, Ankeny DP, Popovich PG (2007) Characterizationand modeling of monocyte-derived macrophages after spinal cord injury. J Neurochem 102:1083-1094.
48. Lu H, Huang D, Saederup N, Charo IF, Ransohoff RM, Zhou L (2011) Macrophagesrecruited via CCR2 produce insulin-like growth factor-1 to repairacute skeletal muscle injury. FASEB J 25:358-369.
49. McCarthy KD, de Vellis J (1980) Preparation of separate astroglial and oligodendroglialcell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
50. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, Mack M, HeikenwalderM, Brück W, Priller J, Prinz M (2007) Microglia in the adultbrain arise from Ly-6ChiCCR2_ monocytes only under defined hostconditions. Nat Neurosci 10:1544-1553.
51. Mildner A, Mack M, Schmidt H, Brück W, Djukic M, Zabel MD, Hille A, Priller J, Prinz M (2009) CCR2+Ly-6Chi monocytes are crucial for theeffector phase of autoimmunity in the central nervous system. Brain132:2487-2500.
52. Mizuno T, Kawanokuchi J, Numata K, Suzumura A (2003) Production andneuroprotective functions of fractalkine in the central nervous system. Brain Res 979:65-70.
53. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ (2007) The healing myocardiumsequentially mobilizes two monocyte subsets with divergent andcomplementary functions. J Exp Med 204:3037-3047.
54. Nanki T, Urasaki Y, Imai T, Nishimura M, Muramoto K, Kubota T, Miyasaka N (2004) Inhibition of fractalkine ameliorates murine collagen-inducedarthritis. J Immunol 173:7010-7016.
55. Oh DJ, Dursun B, He Z, Lu L, Hoke TS, Ljubanovic D, Faubel S, Edelstein CL(2008) Fractalkine receptor (CX3CR1) inhibition is protective againstischemic acute renal failure in mice. Am J Physiol Renal Physiol294:F264-271.
56. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF 3rd (2001) The extra domain A of fibronectin activates Tolllikereceptor 4. J Biol Chem 276:10229-10233.
57. Pachot A, Cazalis MA, Venet F, Turrel F, Faudot C, Voirin N, Diasparra J, Bourgoin N, Poitevin F, Mougin B, Lepape A, Monneret G (2008) Decreasedexpression of the fractalkine receptor CX3CR1 on circulatingmonocytes as new feature of sepsis-induced immunosuppression. J Immunol180:6421-6429.
58. Pineau I, Lacroix S (2007) Proinflammatory cytokine synthesis in the injuredmouse spinal cord: multiphasic expression pattern and identificationof the cell types involved. J Comp Neurol 500:267-285.
59. Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL(2011) MicroRNA-124 promotes microglia quiescence and suppressesEAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat Med 17:64-70.
60. Popovich P, McTigue D (2009) Damage control in the nervous system: bewarethe immune system in spinal cord injury. Nat Med 15:736-737.
61. Popovich PG, Hickey WF (2001) Bone marrow chimeric rats reveal theunique distribution of resident and recruited macrophages in the contusedrat spinal cord. J Neuropathol Exp Neurol 60:676-685.
62. Ransohoff RM, Perry VH (2009) Microglial physiology: unique stimuli,specialized responses. Annu Rev Immunol 27:119-145.
63. Robbins CS, Swirski FK (2010) The multiple roles of monocyte subsets insteady state and inflammation. Cell Mol Life Sci 67:2685-2693.
64. Rodero M, Marie Y, Coudert M, Blondet E, Mokhtari K, Rousseau A, Raoul W, Carpentier C, Sennlaub F, Deterre P, Delattre JY, Debré P, Sanson M, Combadière C (2008) Polymorphism in the microglial cell-mobilizingCX3CR1 gene is associated with survival in patients with glioblastoma.J Clin Oncol 26:5957-5964.
65. Saiwai H, Ohkawa Y, Yamada H, Kumamaru H, Harada A, Okano H, Yokomizo T, Iwamoto Y, Okada S (2010) The LTB4-BLT1 axis mediatesneutrophil infiltration and secondary injury in experimental spinal cordinjury. Am J Pathol 176:2352-2366.
66. Sakurai T, Kaise T, Yadomae T, Matsubara C (1997) Different role of serumcomponents and cytokines on alveolar macrophage activation by solublefungal (1->3)-beta-D-glucan. Eur J Pharmacol 334:255-263.
67. Sedgwick JD, Schwender S, Imrich H, Dörries R, Butcher GW, ter Meulen V(1991) Isolation and direct characterization of resident microglial cellsfrom the normal and inflamed central nervous system. Proc Natl Acad SciU S A 88:7438-7442.
68. Shechter R, London A, Varol C, Raposo C, Cusimano M, Yovel G, Rolls A, Mack M, Pluchino S, Martino G, Jung S, Schwartz M (2009) Infiltratingblood-derived macrophages are vital cells playing an anti-inflammatoryrole in recovery from spinal cord injury in mice. PLoS Med 6:e1000113.
69. Soriano SG, Amaravadi LS, Wang YF, Zhou H, Yu GX, Tonra JR, Fairchild-Huntress V, Fang Q, Dunmore JH, Huszar D, Pan Y (2002) Mice deficientin fractalkine are less susceptible to cerebral ischemia-reperfusioninjury. J Neuroimmunol 125:59-65.
70. Stirling DP, YongVW (2008) Dynamics of the inflammatory response aftermurine spinal cord injury revealed by flow cytometry. J Neurosci Res86:1944-1958.
71. Streit WJ, Davis CN, Harrison JK (2005) Role of fractalkine (CX3CL1) inregulating neuron-microglia interactions: development of viral-basedCX3CR1 antagonists. Curr Alzheimer Res 2:187-189.
72. Sunderkötter C, Nikolic T, Dillon MJ, Van Rooijen N, Stehling M, Drevets DA, Leenen PJ (2004) Subpopulations of mouse blood monocytes differ in maturationstage and inflammatory response. J Immunol 172:4410-4417.
73. Sunnemark D, Eltayeb S, Nilsson M, Wallström E, Lassmann H, Olsson T, Berg AL, Ericsson-Dahlstrand A (2005) CX3CL1 (fractalkine) andCX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimentalautoimmune encephalomyelitis: kinetics and cellular origin. J Neuroinflammation 2:17.
74. Tarozzo G, Campanella M, Ghiani M, Bulfone A, Beltramo M (2002) Expressionof fractalkine and its receptor, CX3CR1, in response to ischaemiareperfusionbrain injury in the rat. Eur J Neurosci 15:1663-1668.
75. Urra X, Villamor N, Amaro S, Gómez-Choco M, Obach V, Oleaga L, Planas AM, Chamorro A (2009) Monocyte subtypes predict clinical course andprognosis in human stroke. J Cereb Blood Flow Metab 29:994-1002.
76. Yang QW, Li JC, Lu FL, Wen AQ, Xiang J, Zhang LL, Huang ZY, Wang JZ(2008) Upregulated expression of toll-like receptor 4 in monocytes correlateswith severity of acute cerebral infarction. J Cereb Blood FlowMetab 28:1588-1596.
77. Zhu B, Bando Y, Xiao S, Yang K, Anderson AC, Kuchroo VK, Khoury SJ(2007) CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmuneencephalomyelitis. J Immunol 179:5228-5237.
78. Zujovic V, Benavides J, Vige ́ X, Carter C, Taupin V (2000) Fractalkine modulatesTNF-alpha secretion and neurotoxicity induced by microglial activation. Glia 29:305-315.